$FZMD
Fuse Medical, Inc.

2017 Q1 Form 10-Q Financial Statement

#000156459017010443 Filed on May 11, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q4 2016 Q1
Revenue $148.2K $25.25M $192.9K
YoY Change -23.21% 5160.42% -25.79%
Cost Of Revenue $48.31K $11.11M $81.28K
YoY Change -40.57% 4730.43% -9.69%
Gross Profit $99.85K $14.13M $111.7K
YoY Change -10.58% 5334.62% -34.32%
Gross Profit Margin 67.39% 55.96% 57.87%
Selling, General & Admin $914.4K $10.64M $230.0K
YoY Change 297.57% 4333.33% -39.47%
% of Gross Profit 915.8% 75.3% 205.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.347K $10.00K $3.642K
YoY Change 46.81% 0.0%
% of Gross Profit 5.36% 0.07% 3.26%
Operating Expenses $3.066M $10.65M $233.8K
YoY Change 1211.26% 4337.5% -40.05%
Operating Profit -$536.3K $3.480M -$122.1K
YoY Change 339.12% 17300.0% -44.48%
Interest Expense $31.95K -$110.0K $0.00
YoY Change
% of Operating Profit -3.16%
Other Income/Expense, Net $11.36K
YoY Change
Pretax Income -$525.0K $3.340M -$120.0K
YoY Change 337.47% 33300.0% -45.45%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$525.0K $3.340M -$123.9K
YoY Change 323.74% 33300.0% -43.69%
Net Earnings / Revenue -354.33% 13.23% -64.21%
Basic Earnings Per Share
Diluted Earnings Per Share -$55.32K $206.3K -$17.42K
COMMON SHARES
Basic Shares Outstanding 5.871M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 Q4 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $450.0K $780.0K $90.00K
YoY Change 400.0% 7700.0% 50.0%
Cash & Equivalents $666.5K $778.4K $85.40K
Short-Term Investments
Other Short-Term Assets $30.00K $20.00K $20.00K
YoY Change 50.0% 0.0% -33.33%
Inventory $21.63K $25.33K $50.00K
Prepaid Expenses
Receivables $122.7K $58.07K $80.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $619.1K $754.4K $240.0K
YoY Change 157.96% 85.72% -48.94%
LONG-TERM ASSETS
Property, Plant & Equipment $6.467K $8.931K $20.00K
YoY Change -67.67% -64.24% -50.0%
Goodwill $820.0K
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00 $0.00
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $10.29K $18.82M $20.00K
YoY Change -48.56% 65252.1% -60.0%
TOTAL ASSETS
Total Short-Term Assets $619.1K $754.4K $240.0K
Total Long-Term Assets $10.29K $18.82M $20.00K
Total Assets $629.4K $19.58M $260.0K
YoY Change 142.07% 4400.13% -50.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $74.55K $2.453M $260.0K
YoY Change -71.33% 892.37% 23.81%
Accrued Expenses $28.71K $5.097K $20.00K
YoY Change 43.57% -58.45% -33.33%
Deferred Revenue
YoY Change
Short-Term Debt $150.0K $3.460M $0.00
YoY Change
Long-Term Debt Due $100.0K
YoY Change 400.0%
Total Short-Term Liabilities $294.7K $8.976M $380.0K
YoY Change -22.44% 2619.7% 46.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $294.7K $8.976M $380.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $295.2K $316.5K $380.0K
YoY Change -22.32% -26.4% 5.56%
SHAREHOLDERS EQUITY
Retained Earnings -$3.017M -$2.901M
YoY Change 25.31%
Common Stock $3.352M $3.352M
YoY Change 44.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $334.2K $10.60M -$120.0K
YoY Change
Total Liabilities & Shareholders Equity $629.4K $767.1K $260.0K
YoY Change 142.07% 76.35% -50.0%

Cashflow Statement

Concept 2017 Q1 2016 Q4 2016 Q1
OPERATING ACTIVITIES
Net Income -$525.0K $3.340M -$123.9K
YoY Change 323.74% 33300.0% -43.69%
Depreciation, Depletion And Amortization $5.347K $10.00K $3.642K
YoY Change 46.81% 0.0%
Cash From Operating Activities $740.0K $2.840M $80.00K
YoY Change 825.0% -5780.0% -126.67%
INVESTING ACTIVITIES
Capital Expenditures $20.33K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $660.0K $0.00
YoY Change
Cash From Investing Activities -$20.00K $660.0K $0.00
YoY Change -6700.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -830.0K -3.030M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 740.0K 2.840M 80.00K
Cash From Investing Activities -20.00K 660.0K 0.000
Cash From Financing Activities -830.0K -3.030M 0.000
Net Change In Cash -110.0K 470.0K 80.00K
YoY Change -237.5% -883.33% -900.0%
FREE CASH FLOW
Cash From Operating Activities $740.0K $2.840M $80.00K
Capital Expenditures $20.33K $0.00
Free Cash Flow $719.7K $2.840M
YoY Change -7200.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Assets
Assets
629386
CY2016Q4 us-gaap Assets
Assets
767147
CY2017Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
41042
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
83410
CY2017Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
3822
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
74553
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15890808
CY2016Q1 us-gaap Revenues
Revenues
192943
CY2017Q1 us-gaap Assets Current
AssetsCurrent
619097
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
445520
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
315845
CY2016Q4 us-gaap Assets Current
AssetsCurrent
754394
CY2016Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
150000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5097
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
58065
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
667475
CY2016Q4 us-gaap Inventory Net
InventoryNet
25326
CY2016Q4 us-gaap Liabilities
Liabilities
316532
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
122677
CY2017Q1 us-gaap Inventory Net
InventoryNet
21628
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3528
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29272
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6467
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8931
CY2016Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
3822
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
150000
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
158908
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
294721
CY2017Q1 us-gaap Liabilities
Liabilities
295179
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3192686
CY2017Q1 dei Trading Symbol
TradingSymbol
FZMD
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
81281
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3017387
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15890808
CY2017Q1 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017Q1 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15890808
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28714
CY2017Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
250742
CY2016Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
228577
CY2017Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-307
CY2016Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1580
CY2017Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
458
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q1 us-gaap Depreciation
Depreciation
1857
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
252906
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
233799
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-153058
CY2017Q1 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
6658
CY2016Q1 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
1750
CY2017Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
43308
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-116408
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-123887
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15890808
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6890808
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
64612
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-213866
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3699
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-34296
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
25744
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
316
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
34451
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-54166
CY2017Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-36136
CY2016Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-1991
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
23616
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3643
CY2017Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-23
CY2016Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-275
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-222255
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
76942
CY2017Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
300
CY2016Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
300
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
300
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
300
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-221955
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
77242
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
160
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
687
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
158908
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
629386
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3192686
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
334207
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2900979
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
767147
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
450615
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
48309
CY2016Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
77178
CY2017Q1 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
412
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15890808
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15890808
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-122137
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q1 us-gaap Revenues
Revenues
148157
CY2017Q1 us-gaap Gross Profit
GrossProfit
99848
CY2016Q1 us-gaap Gross Profit
GrossProfit
111662
CY2016Q1 us-gaap Depreciation
Depreciation
3642
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8157
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85399
CY2016Q1 us-gaap Interest Paid
InterestPaid
1750
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed financial statements.&nbsp;&nbsp;Actual results could differ from those estimates.&nbsp;&nbsp;Significant estimates in the accompanying condensed financial statements include the allowance for doubtful accounts, valuation of inventories, the estimates of fixed assets useful lives, the valuation of property and equipment, the valuation allowance on deferred tax assets, and the fair value calculation of stock-based awards.</p></div>
CY2017Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2017Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="text-align:justify;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain amounts in the accompanying condensed financial statements as of March 31, 2016, and for the three-months then ended, have been reclassified to conform to the March 31, 2017 condensed financial statements for the three-months then ended. These include deferred rent and depreciation expense, previously reported as a component of General, administrative and other and Accrued expenses, respectively.</p></div>
CY2016Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
421636
CY2017Q1 fzmd Options To Purchase Included In Common Stock Equivalents
OptionsToPurchaseIncludedInCommonStockEquivalents
1304788
CY2016Q1 fzmd Options To Purchase Included In Common Stock Equivalents
OptionsToPurchaseIncludedInCommonStockEquivalents
609576
CY2017Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2016Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2017Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2017Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
237803
CY2017Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0
CY2017Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14221
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43945
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7754
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35014
CY2017Q1 us-gaap Loss Contingency Lawsuit Filing Date
LossContingencyLawsuitFilingDate
January 27, 2014
CY2017Q1 us-gaap Loss Contingency Name Of Plaintiff
LossContingencyNameOfPlaintiff
M. Richard Cutler and Cutler Law Group, P.C.
CY2017Q1 us-gaap Loss Contingency Name Of Defendant
LossContingencyNameOfDefendant
Fuse, Alan Meeker, Rusty Shelton, Jonathan Brown, Robert H. Donehew and GolfRounds.com, Inc.
CY2017Q1 us-gaap Loss Contingency Date Of Dismissal
LossContingencyDateOfDismissal
2014-04-21
CY2017Q1 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
70000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1304788
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1304788
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1304788
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.22
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.22
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.22
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3M18D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
35000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
183000
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
183000

Files In Submission

Name View Source Status
0001564590-17-010443-index-headers.html Edgar Link pending
0001564590-17-010443-index.html Edgar Link pending
0001564590-17-010443.txt Edgar Link pending
0001564590-17-010443-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fzmd-10q_20170331.htm Edgar Link pending
fzmd-20170331.xml Edgar Link completed
fzmd-20170331.xsd Edgar Link pending
fzmd-20170331_cal.xml Edgar Link unprocessable
fzmd-20170331_def.xml Edgar Link unprocessable
fzmd-20170331_lab.xml Edgar Link unprocessable
fzmd-20170331_pre.xml Edgar Link unprocessable
fzmd-ex311_10.htm Edgar Link pending
fzmd-ex312_8.htm Edgar Link pending
fzmd-ex321_9.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending